ClynavTM solution for injection for Atlantic salmon
CLYNAV is a vaccine (0.05 ml dose) used to protect Atlantic salmon against pancreas disease caused by salmonid alphavirus subtype 3 (SAV3).
Presentation
A clear, colourless, particulate-free solution.
Active ingredients
Active substance: pUK-SPDV-poly2#1 DNA plasmid coding for salmon pancreas disease virus proteins:
6.0 – 9.4 μg.
Target species
Atlantic salmon (Salmo salar).
Indications for use
For the active immunisation of Atlantic salmon to reduce impaired daily weight gain, and reduce mortality, and cardiac, pancreatic and skeletal muscle lesions caused by pancreas disease following infection with salmonid alphavirus subtype 3 (SAV3).
Onset of immunity occurs within 399 degree days (mean water temperature in °C multiplied by number of holding days) following vaccination.
Duration of immunity: 1 year for reduction in impaired daily weight gain, and cardiac, pancreatic and skeletal muscle lesions and 9.5 months for reduction of mortality (demonstrated in a laboratory efficacy study in saltwater conditions using a cohabitation challenge model).
Withdrawal periods
Zero degree days
Packaging
250 ml sterile, flexible, ethyl vinyl acetate (EVA) bags with a locking snap down port. A sterile and individually packaged transfer tube set is included in the final product packaging.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: July 2024